Generation of hepatitis C virusresistant liver cells by genome editingmediated stable expression of RNA aptamer: Molecular Therapy Methods & Clinical Development Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open label, randomised, phase 2 trial The Lancet Infectious Diseases Melanosis Coli Treatment & Management Point of Care StatPearls Rapid point of care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection